FDG PET/CT before and after selective internal radiation therapy (SIRT) can help predict survival among patients with breast cancer with hepatic metastases, researchers found.
FDG PET/CT before and after selective internal radiation therapy (SIRT) can help predict survival among patients with breast cancer with hepatic metastases, researchers found.
A study published in the March issue of the Journal of Nuclear Medicine involved 58 women with breast cancer who underwent SIRT a mean of 467 weeks +/- 365 weeks following initial diagnosis. The patients underwent both a whole-body FDG PET/CT 3D scan and contrast-enhanced MRI of the liver before beginning treatment. These were repeated three months following treatment in 43 of the patients.
The researchers measured the maximum standardized uptake value (SUVMAX) of the hepatic metastases and compared the findings from the second exam to the first. They used up to five of the most notable hepatic metastases.
Researchers found that patients who responded favorably to the treatment, having a greater chance of survival, had a decrease of greater than 30 percent from baseline; those who had new metastases or a decrease of less than 30 percent meant poor or no response, and did not predict survival. “Furthermore, a high pretherapeutic SUVMAX (higher than 20) was associated with a significantly shorter median survival than was an SUVMAX of equal to or lower than 20,” wrote the authors.
Overall median survival after SIRT was 47 weeks, 65 weeks for favorable responders and 43 weeks for non-responders. Of the 43 patients who were tested after treatment, 11 (26 percent) had partial response to treatment, 27 (63 percent) had stable disease, and five (11 percent) had progressive disease.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.